Results 61 to 70 of about 1,763,654 (403)

Breast Metastasis from Neuroendocrine Carcinoma of the Lung: A Case Report and Review of the Literature

open access: yesCase Reports in Oncology, 2020
Breast metastasis originating from non-mammary tumors is an uncommon event accounting for 0.5–6.6% of all breast neoplasms. The primary malignancies that reportedly metastasize to the breast most frequently are hematologic malignancies, such as leukemia ...
Panagiota Economopoulou   +7 more
doaj   +1 more source

MUC1 positive cutaneous metastasis with transepidermal elimination from a breast carcinoma [PDF]

open access: yes, 2013
Breast cancer is the most common cause of cutaneous metastases from internal malignancies. Generally, the neoplastic cells are located in the dermis or hypodermis, while a finding of transepidermal elimination on cutaneous metastases is exceptional.
Abba, Martín Carlos   +5 more
core   +3 more sources

Tumor heterogeneity in neoplasms of breast, colon, and skin [PDF]

open access: yesBMC Research Notes, 2010
Different cell subpopulations in a single tumor may show diverse capacities for growth, differentiation, metastasis formation, and sensitivity to treatments. Thus, heterogeneity is an important feature of tumors. However, due to limitations in experimental and analytical techniques, tumor heterogeneity has rarely been studied in detail.Different tumor ...
Li, Jian   +5 more
openaire   +5 more sources

Rare incidence of diffuse large B-cell lymphoma (DLBCL) with bilateral breast and testicular involvement in a male patient: A case report and review of the literature

open access: yesCurrent Problems in Cancer: Case Reports, 2022
Background: Breast lymphomas are a rare group of neoplasms that can be further categorized as Primary Breast Lymphomas (PBL) or secondary breast lymphomas.
Sarah Ayad   +3 more
doaj  

Issues of breast cancer diagnosis

open access: yesКлинический разбор в общей медицине, 2023
Today, most of patients with malignant neoplasms are patients with breast cancer, BC (18.3% of all malignant neoplasms). The increase in the diagnosis rate of stage I–II BC is observed since 2011: this indicator was 65% in 2011 and 72.5% in 2021 ...
Elena V. Litvyakova   +7 more
doaj   +1 more source

The power of microRNA regulation—insights into immunity and metabolism

open access: yesFEBS Letters, EarlyView.
MicroRNAs are emerging as crucial regulators at the intersection of metabolism and immunity. This review examines how miRNAs coordinate glucose and lipid metabolism while simultaneously modulating T‐cell development and immune responses. Moreover, it highlights how cutting‐edge artificial intelligence applications can identify miRNA biomarkers ...
Stefania Oliveto   +2 more
wiley   +1 more source

Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin's Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study. [PDF]

open access: yes, 2015
Background Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers.
Alfieri, R   +11 more
core   +7 more sources

Breast radiation-associated secondary malignancies: A review

open access: yesClinical Surgical Oncology, 2023
Secondary malignancies are a late complication of radiation treatment for primary cancer through DNA damage. Specifically after breast cancer radiation, a number of tissues are vulnerable to radiation damage and have increased risk for developing ...
Sarah Poland   +3 more
doaj  

Changes in the activity of adenosine deaminase and the content of polyamines in the blood of cats with breast cancer [PDF]

open access: yesE3S Web of Conferences, 2019
In this work, the clinical significance of changes in the activity of adenosine deaminase (ADA) and the content of polyamines in the blood plasma of cats with breast cancer was studied.
Vakulenko Maya   +4 more
doaj   +1 more source

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.

open access: yesJournal of Clinical Oncology, 2015
PURPOSE Outcomes for early-stage breast cancer have improved. First-generation adjuvant chemotherapy trials reported a 0.27% 8-year cumulative incidence of myelodysplastic syndrome/acute myelogenous leukemia.
A. Wolff   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy